Related references
Note: Only part of the references are listed.Learning from the Past and Looking to the Future
Alexander M. Capron
JOURNAL OF NUTRIGENETICS AND NUTRIGENOMICS (2009)
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
Jean-Philippe Collet et al.
LANCET (2009)
Genetic Screening: Programs, Principles, and Research - Thirty Years Later Reviewing the Recommendations of the Committee for the Study of Inborn Errors of Metabolism (SIEM)
A. P. Simicipoulos
PUBLIC HEALTH GENOMICS (2009)
Clinical trials and clinical judgment
Anthony N. DeMaria
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Letting the genome out of the bottle - Will we get our wish?
David J. Hunter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKCε inhibition
Marika Massaro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Nutrigenomics and nutrigenetics: the emerging faces of nutrition
DM Mutch et al.
FASEB JOURNAL (2005)
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S Yusuf et al.
LANCET (2004)
Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis
JH Dwyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Postmenopausal hormone-replacement therapy.
JE Manson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)